Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Cash & Current Investments: 2020-2025

Historic Cash & Current Investments for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to $2.8 million.

  • iSpecimen's Cash & Current Investments rose 58.85% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year decrease of 47.38%. This contributed to the annual value of $1.9 million for FY2024, which is 62.47% down from last year.
  • iSpecimen's Cash & Current Investments amounted to $2.8 million in Q3 2025, which was up 372.64% from $588,775 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Cash & Current Investments ranged from a high of $27.7 million in Q4 2021 and a low of $588,775 during Q2 2025.
  • Its 3-year average for Cash & Current Investments is $3.9 million, with a median of $2.6 million in 2024.
  • In the last 5 years, iSpecimen's Cash & Current Investments soared by 3,886.01% in 2021 and then crashed by 76.81% in 2024.
  • iSpecimen's Cash & Current Investments (Quarterly) stood at $27.7 million in 2021, then tumbled by 44.81% to $15.3 million in 2022, then tumbled by 67.30% to $5.0 million in 2023, then slumped by 62.47% to $1.9 million in 2024, then soared by 58.85% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q3 2025, $588,775 for Q2 2025, and $782,563 during Q1 2025.